Company
Pharmasum Therapeutics
- Biotech
- Location:
- Oslo (Oslo, Norway)
Description
Pharmasum Therapeutics develops small-molecule drugs for neurological diseases, advancing proprietary DYRK1A inhibitor PST-674 for dementia-related indications including Alzheimer’s, Parkinson’s and Down syndrome.
Related
BIMINI BiotechBIMINI Biotech develops first-in-class small-molecule therapeutics modulating the Wiskott–Aldrich Syndrome protein for oncology and…
Herantis PharmaHerantis Pharma develops neurorestorative therapies and clinical-stage products for Parkinson’s disease, including the HER-096 program,…
ATXA THERAPEUTICSATXA THERAPEUTICS develops selective small-molecule thromboxane receptor (TP) antagonists and clinical candidate NTP42 for cardiopulmonary…
BrainEverBrainEver develops homeoprotein-based biopharmaceutical therapies to halt neurodegenerative disease progression, producing drug candidates…
Eli Lilly ($LLY)Indianapolis-headquartered pharmaceutical giant; one of the most valuable US biotechs.
Esperion Therapeutics ($ESPR)Esperion Therapeutics develops and commercializes oral cardiovascular therapies that lower cholesterol and related risk factors, and…
Crinetics PharmaceuticalsCrinetics Pharmaceuticals develops orally delivered endocrine-targeted therapeutics, designing and advancing small-molecule drugs for…
Karyopharm Therapeutics ($KPTI)Karyopharm Therapeutics develops and commercializes cancer therapies, including oral nuclear export inhibitors, for patients with multiple…
Heartbeat BioHeartbeat Bio builds proprietary Cardioid human heart chamber models and assay platforms for disease-relevant cardiac drug discovery,…
Anacalypsis TherapeuticsAnacalypsis Therapeutics develops gene-based therapeutics and multiplex biomarkers for Parkinson's disease and other neurodegenerative…
Genesis TherapeuticsGenesis Therapeutics develops AI-driven molecular design models and an integrated platform to generate, evaluate, and optimize…
Kyverna Therapeutics ($KYTX)Kyverna Therapeutics develops CAR T-cell therapies for autoimmune diseases, with clinical trials addressing conditions including stiff…